Settlement Highlights Ongoing Interest in Kickbacks Affecting Non-Federal Healthcare Programs
Earlier this week, two laboratory testing companies paid $42.25 million to resolve allegations that they violated the California and federal FCAs, as well as the California Insurance Frauds Prevention Act, by paying kickbacks to induce physicians to order a specialized lab test for auto-immune and inflammatory diseases.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.